Unique Fabricating (UFABQ) 10-Q 12 Aug 21 2021 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2021	Jul. 30, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2021
Document Transition Report	false
Entity File Number	001-37480
Entity Registrant Name	UNIQUE FABRICATING, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-1846791
Entity Address, Address Line One	800 Standard Parkway
Entity Address, City or Town	Auburn Hills
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48326
City Area Code	248
Local Phone Number	853-2333
Title of 12(b) Security	Common Stock, par value $.001 per share
Trading Symbol	UFAB
Security Exchange Name	NYSEAMER
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		9,779,147
Entity Central Index Key	0001617669
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 924	$ 760
Accounts receivable, net of reserves of approximately $1.0 million and $1.2 million at June 30, 2021 and December 31, 2020, respectively	25,643	23,759
Inventory, net	15,300	11,951
Prepaid expenses and other current assets:
Prepaid expenses and other	3,127	5,643
Refundable taxes	4,102	4,027
Total current assets	49,096	46,140
Property, plant, and equipment, net	23,100	22,383
Goodwill	22,111	22,111
Intangible assets	6,175	7,605
Other assets
Operating	9,274	10,415
Investments, at cost	1,054	1,054
Deposits and other assets	498	579
Deferred tax asset	893	893
Total assets	112,201	111,180
Current liabilities:
Accounts payable	12,329	10,892
Current maturities of long-term debt	36,943	35,864
Income taxes payable	451	204
Revolver, current maturities	17,537	11,494
Accrued compensation	1,396	792
Other accrued liabilities	3,936	4,551
Total current liabilities	72,592	63,797
Long-term debt, net of current maturities	0	2,999
Other long-term liabilities:
Other liabilities	9,039	10,519
Total liabilities	81,631	77,315
Stockholders’ equity:
Common stock, $0.001 par value: 15,000,000 shares authorized and 9,779,147 and 9,779,147 issued and outstanding at June 30, 2021 and December 31, 2020, respectively	10	10
Additional paid-in-capital	46,409	46,126
Accumulated deficit	(15,849)	(12,271)
Total stockholders’ equity	30,570	33,865
Total liabilities and stockholders’ equity	$ 112,201	$ 111,180

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Allowance for doubtful accounts receivable	$ 1	$ 1.2
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	15,000,000	15,000,000
Common stock, shares issued (in shares)	9,779,147	9,779,147
Common stock, shares outstanding (in shares)	9,779,147	9,779,147

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Net sales	$ 30,896	$ 14,975	$ 65,694	$ 49,636
Cost of sales	26,280	13,134	55,216	42,204
Gross profit	4,616	1,841	10,478	7,432
Selling, general, and administrative expenses	6,081	6,343	11,895	12,227
Restructuring expenses	0	273	0	1,193
Operating income (loss)	(1,465)	(4,775)	(1,417)	(5,988)
Other income (expense):
Other, net	21	18	39	(6)
Interest expense	(769)	(623)	(1,462)	(2,289)
Other expense, net	(748)	(605)	(1,423)	(2,295)
Loss before income tax expense (benefit)	(2,213)	(5,380)	(2,840)	(8,283)
Income tax expense (benefit)	296	(1,058)	738	(1,659)
Net loss	$ (2,509)	$ (4,322)	$ (3,578)	$ (6,624)
Net loss per share:
Basic (in dollars per share)	$ (0.26)	$ (0.44)	$ (0.37)	$ (0.68)
Diluted (in dollars per share)	$ (0.26)	$ (0.44)	$ (0.37)	$ (0.68)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Stockholders' equity, beginning balance (in shares) at Dec. 29, 2019		9,779,147
Stockholders' equity, beginning balance at Dec. 29, 2019	$ 39,460	$ 10	$ 46,011	$ (6,561)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,302)
Stock option expense	23		23
Stockholders' equity, ending balance (in shares) at Mar. 31, 2020		9,779,147
Stockholders' equity, ending balance at Mar. 31, 2020	37,181	$ 10	46,034	(8,863)
Stockholders' equity, beginning balance (in shares) at Dec. 29, 2019		9,779,147
Stockholders' equity, beginning balance at Dec. 29, 2019	39,460	$ 10	46,011	(6,561)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(6,624)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2020		9,779,147
Stockholders' equity, ending balance at Jun. 30, 2020	32,891	$ 10	46,066	(13,185)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2020		9,779,147
Stockholders' equity, beginning balance at Mar. 31, 2020	37,181	$ 10	46,034	(8,863)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(4,322)
Stock option expense	32		32
Stockholders' equity, ending balance (in shares) at Jun. 30, 2020		9,779,147
Stockholders' equity, ending balance at Jun. 30, 2020	32,891	$ 10	46,066	(13,185)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2020		9,779,147
Stockholders' equity, beginning balance at Dec. 31, 2020	33,865	$ 10	46,126	(12,271)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,069)			(1,069)
Stock option expense	27		27
Stockholders' equity, ending balance (in shares) at Mar. 31, 2021		9,779,147
Stockholders' equity, ending balance at Mar. 31, 2021	32,823	$ 10	46,153	(13,340)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2020		9,779,147
Stockholders' equity, beginning balance at Dec. 31, 2020	33,865	$ 10	46,126	(12,271)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,578)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2021		9,779,147
Stockholders' equity, ending balance at Jun. 30, 2021	30,570	$ 10	46,409	(15,849)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2021		9,779,147
Stockholders' equity, beginning balance at Mar. 31, 2021	32,823	$ 10	46,153	(13,340)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,509)			(2,509)
Stock option expense	256		256
Stockholders' equity, ending balance (in shares) at Jun. 30, 2021		9,779,147
Stockholders' equity, ending balance at Jun. 30, 2021	$ 30,570	$ 10	$ 46,409	$ (15,849)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash Flows from Operating Activities:
Net loss	$ (3,578)	$ (6,624)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,953	3,458
Amortization of debt issuance costs	103	74
Loss on sale of assets	(12)	108
Bad debt adjustment	(194)	554
Loss (gain) on derivative instrument	(185)	598
Stock option expense	283	55
Deferred income taxes	0	(1,864)
Accounts receivable	(1,690)	8,464
Inventory	(3,349)	(1,694)
Prepaid expenses and other assets	2,520	(1,809)
Accounts payable	2,148	(1,228)
Other assets and liabilities, net	88	601
Net cash provided by (used for) operating activities	(913)	693
Cash Flows from Investing Activities:
Capital expenditures	(2,327)	(760)
Proceeds from sale of property, plant and equipment	100	884
Net cash provided by (used for) investing activities	(2,227)	124
Cash Flows from Financing Activities:
Net change in bank overdraft	(711)	(311)
Payments on term loans and capital expenditure line	(1,989)	(1,474)
Payments on revolving credit facilities	(16,925)	(12,310)
Proceeds from revolving credit facilities	22,929	10,727
Proceeds from PPP Note	0	5,999
Net cash provided by financing activities	3,304	2,631
Cash and cash equivalents:
Net increase in cash and cash equivalents	164	3,448
Cash and cash equivalents at beginning of period	760	650
Cash and cash equivalents at end of period	924	4,098
Supplemental disclosure of cash flow information:
Cash paid for interest	1,569	2,219
Cash paid for income taxes	$ 353	$ 209

Nature of Business and Basis of

Nature of Business and Basis of Presentation	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Nature of Business and Basis of Presentation	Nature of Business and Basis of Presentation Nature of Business Unique Fabricating, Inc. (the “Company”) engineers and manufactures components for customers in the transportation, appliance, medical, and consumer off-road markets. The Company’s solutions are comprised of multi-material foam, rubber, and plastic components, and utilized in noise, vibration and harshness (“NVH”) management, acoustical management, water and air sealing, decorative and other functional applications. The Company leverages proprietary manufacturing processes, including die cutting, thermoforming, compression molding, fusion molding, and reaction injection molding to manufacture a wide range of products including air management products, heating, ventilating, and air conditioning (“HVAC”), seals, fender stuffers, air ducts, acoustical insulation, door water shields, gas tank pads, light gaskets, topper pads, mirror gaskets, glove box liners, personal protection equipment, and packaging. The Company operates as one reportable segment and is headquartered in Auburn Hills, Michigan. Basis of Presentation The Company’s condensed consolidated financial statements have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements contain all material adjustments (consisting only of normal recurring adjustments) necessary to present fairly the consolidated financial position of the Company, its results of operations, and its cash flows. The interim results for the periods presented may not be indicative of the Company's actual annual results. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Going Concern The Company’s consolidated financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company’s financial results for the six months ended December 31, 2020, and the nine months ended March 31, 2021, resulted in violations of certain of its financial covenants, as defined in the Company’s Credit Agreement ( Note 6 ). As a result of the default, the lenders may accelerate the maturity of the debt and accordingly all debt subject to the Credit Agreement, totaling $48.5 million, has been classified as current as of June 30, 2021. On April 9, 2021, the Company and its lenders entered into a forbearance agreement through and including June 15, 2021, during which the Company was able to borrow on its revolving line of credit, subject to availability and the satisfaction of certain other conditions, and the Lenders agreed not to accelerate the maturity of the Company’s debt during the forbearance period. On June 14, 2021 the Company entered into the First Amendment to Forbearance Agreement, which among other things, extended the forbearance period from June 15, 2021 to February 28, 2022, suspended the testing of the Total Leverage Ratio and the Debt Service Ratio during the forbearance period and included revised requirements for Minimum Liquidity and Minimum Consolidated EBITDA, as defined, for the monthly periods through and including February 28, 2022, beginning with the month ending July 31, 2021. During the extended period, the Company will continue to be able to borrow under the revolving line of credit, subject to availability and the satisfaction of certain other conditions, including compliance with financial covenants. Please refer to Note 6 Long-term Debt for more information. However, the Company does not have sufficient cash and cash equivalents on hand or other available sources of liquidity to repay outstanding debt under the Credit Agreement at expiration of the Forbearance Agreement, as amended. These events and conditions raise substantial doubt about the Company’s ability to continue as a going concern for the one-year period following the date that these financial statements are issued. In response to these conditions, the Company has been actively pursuing with Citizens Bank, National Association (“Citizens”), acting as lender and Administrative Agent, and the other lenders (collectively, the “Lenders”) a waiver of the violations at December 31, 2020 and March 31, 2021 or amendment of its financial covenants prior to expiration of the Forbearance Agreement as amended. However, these discussions have not been finalized and are not within the Company’s control, and therefore cannot be deemed probable. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern. As described in Note 6 to these condensed consolidated financial statements, the Company’s Forbearance Agreement, as amended, contains certain financial covenants with which we are required to comply, commencing with the four-month period ending July 31, 2021, through and including the eleven-month period ending February 28, 2022. There cannot be any assurance that the Company will be able to comply with these covenants contained in the Forbearance Agreement, including as soon as with respect to the first measurement period, given the industry-wide and other challenges that the Company is currently facing, as described elsewhere herein or that our lenders would waive a default if that were to occur. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. Concentration Risks The Company is exposed to significant concentration risks as follows: Customer and Credit — During the three and six months ended June 30, 2021 and June 30, 2020, the Company’s net sales were principally derived from customers engaged in the North American automotive industry. The following table presents the Company's sales directly to General Motors Company (“GM”), Yanfeng Automotive Interiors, Stellantis N.V. (formerly Fiat Chrysler Automobiles), and Ford Motor Company (“Ford”) as a percentage of total net sales: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 General Motors Company 13 % 8 % 10 % 9 % Yanfeng Automotive Interiors 7 % 5 % 7 % 7 % Stellantis N.V. 6 % 4 % 6 % 5 % Ford Motor Company 2 % 4 % 4 % 5 % Furthermore, the Company had additional sales to the customers listed in the above table indirectly through other customers. Labor Markets — At June 30, 2021, of the Company’s hourly plant employees working in the United States manufacturing facilities, 33% were covered under a collective bargaining agreement which expires in August 2022 while another 13% were covered under a separate collective bargaining agreement that expires in February 2023. The remaining US employees are not part of a union. International Operations — The Company manufactures and sells products outside of the United States primarily in Mexico and Canada. Foreign operations are subject to various political, economic and other risks and uncertainties inherent in foreign countries. Among other risks, the Company’s operations may be subject to the risks of: restrictions on transfers of funds; export duties, quotas, and embargoes; domestic and international customs and tariffs; changing taxation policies; foreign exchange restrictions; political conditions; and governmental regulations. The following table presents the percentage of the Company's total production in Mexico and Canada: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Mexico 26 % 20 % 24 % 22 % Canada 10 % 12 % 10 % 9 % The following table presents the percentage of the Company's total net sales represented by net sales from operations located in Mexico and Canada: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Mexico 26 % 17 % 25 % 21 % Canada 10 % 9 % 10 % 8 %

New Accounting Pronouncements

New Accounting Pronouncements	6 Months Ended
	Jun. 30, 2021
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses,” which introduced new guidance for an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Instruments in scope include loans, held-to-maturity debt securities, and net investments in leases as well as reinsurance and trade receivables. In November 2018, the FASB issued ASU 2018-19, which clarifies that operating lease receivables are outside the scope of the new standard. In November 2019, the FASB issued ASU 2019-10, which established the effective date of the new standard for smaller reporting companies as fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact, if any, the adoption of the new credit losses model will have on its financial statements. In February 2016, the FASB issued ASU 2016-2, Leases (Topic 842). This update requires lessees to recognize on the balance sheet assets and liabilities for the rights and obligations created by leases of greater than twelve months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. We have identified our existing lease contracts and calculated the right of use assets, which are reflected in Other Assets on the Condensed Consolidated Balance Sheets, and lease liabilities, which are reflected in the Other Accrued Liabilities on the Condensed Consolidated Balance Sheets. This guidance was effective for the Company as of January 1, 2020. Adoption of the new standard resulted in the recording of right-of-use assets and liabilities of $12.1 million and $12.8 million, respectively, as of January 1, 2020. The FASB has issued further ASUs related to the standard providing an optional transition method allowing entities to not recast comparative periods. The Company elected the practical expedients upon transition that retained the lease classification and initial direct costs for any leases that exist prior to adoption of the standard. The Company has approximately $10.1 million of non-cancelable future rental obligations as of June 30, 2021, as shown in Note 11. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740). The guidance simplifies accounting for income taxes by removing certain exceptions. This new guidance is effective for fiscal years beginning after December 15, 2020 for public companies. The Company adopted this guidance on a prospective basis and there was no material impact. In March 2020, the FASB issued ASU No. 2020-04 “Reference Rate Reform”. The ASU provides temporary optional guidance to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or any other reference rate expected to be discontinued. The ASU is intended to help stakeholders during the global market-wide reference rate transition period. Therefore, it will be in effect for a limited time through December 31, 2022. The Company is currently assessing which contracts may be affected.

Revenues

Revenues	6 Months Ended
	Jun. 30, 2021
Revenue from Contract with Customer [Abstract]
Revenues	Revenues The following table presents the Company's net sales disaggregated by major sales channel for the three and six months ended June 30, 2021 and 2020: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 (dollars in thousands) Net Sales Transportation $ 27,373 $ 11,290 $ 58,617 $ 42,986 Appliance 3,008 2,132 6,143 4,912 Other 515 1,553 934 1,738 Total $ 30,896 $ 14,975 $ 65,694 $ 49,636 General Recognition Policy Revenue is recognized by the Company once all performance obligations under the terms of a contract with a Company's customer is satisfied. Generally this occurs with the transfer of control to a customer of its transportation, appliance, and other products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring its products. The Company’s payment terms vary by the type and location of its customers and the products offered. The term between invoicing and when payment is due is not significant. In general for sales arrangements, the Company deems control to transfer at a single point in time and recognizes revenue when it ships products from its manufacturing facilities to its customers. Once a product has shipped, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to transfer upon shipment because the Company has a present right to payment at that time, the customer has legal title to the asset, and the customer has significant risks and rewards of ownership of the asset. Contract Balances

Inventory

Inventory	6 Months Ended
	Jun. 30, 2021
Inventory Disclosure [Abstract]
Inventory	Inventory Inventories consist of the following: June 30, December 31, (dollars in thousands) Raw materials $ 9,759 $ 7,366 Work in progress 1,172 1,225 Finished goods 4,369 3,360 Total inventory $ 15,300 $ 11,951 The Company periodically evaluates inventory for obsolescence, excess quantities, slow moving goods and other impairments of value and establishes reserves for any identified impairments. The allowance for obsolete inventory was $0.9 million at June 30, 2021 and $0.4 million at December 31, 2020. Included in inventory are assets located in Mexico with a carrying amount of $3.8 million at June 30, 2021 and $3.1 million million at December 31, 2020, and assets located in Canada with a carrying amount of $1.1 million at June 30, 2021 and $1.1 million at December 31, 2020.

Property, Plant, and Equipment,

Property, Plant, and Equipment, Net	6 Months Ended
	Jun. 30, 2021
Property, Plant and Equipment [Abstract]
Property, Plant, and Equipment, Net	Property, Plant, and Equipment, Net Property, plant, and equipment, net consists of the following: June 30, December 31, Depreciable (dollars in thousands) Land $ 538 $ 538 Buildings 6,923 6,923 23 – 40 Shop equipment 25,012 23,436 7 – 10 Leasehold improvements 1,269 1,245 3 – 10 Office equipment 2,884 2,331 3 – 7 Mobile equipment 50 152 3 Construction in progress 2,376 2,315 Total cost 39,052 36,940 Less: Accumulated depreciation 15,952 14,557 Net property, plant, and equipment, net $ 23,100 $ 22,383 Depreciation expense was $0.8 million and $1.5 million for the three and six months ended June 30, 2021, respectively, and $0.7 million and $1.4 million for the three and six months ended June 30, 2020, respectively. Included in property, plant, and equipment, net are assets located in Mexico with a carrying amount of $3.8 million and $3.7 million at June 30, 2021 and December 31, 2020, respectively, and assets located in Canada with a carrying amount of $0.4 million and $0.4 million at June 30, 2021 and December 31, 2020, respectively.

Long-term Debt

Long-term Debt	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Long-term Debt	Long-term Debt The Company’s long-term debt consists of the following: June 30, December 31, (dollars in thousands) U.S. Small Business Administration Paycheck Protection Program loan (PPP Note), payable in equal monthly installments on the first day after the deferment period. The PPP Note is unsecured and bears interest at 1% per annum. The PPP Note may be forgiven subject to the terms of the Paycheck Protection Program. $ 5,999 $ 5,999 US Term Loan, payable to lenders in quarterly installments of $0.6 million through September 30, 2021 and $0.8 million through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at June 30, 2021. At June 30, 2021, the balance of the US Term Loan is presented net of a debt discount of $0.2 million from costs paid to or on behalf of the lenders. 21,665 22,768 CA Term Loan, payable to lenders in quarterly installments of $0.4 million through November 7, 2023, with a lump sum due at maturity. The effective interest rate was 5.5% per annum at June 30, 2021. At June 30, 2021, the balance of the CA Term Loan is presented net of a debt discount of $0.1 million from costs paid to or on behalf of the lenders. 8,145 8,876 Capital expenditure line payable to lenders in quarterly installments of 10% per annum through September 30, 2021, and 12.5% per annum through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at June 30, 2021. 1,134 1,220 Total debt excluding Revolver 36,943 38,863 Less current maturities 36,943 35,864 Long-term debt – Less current maturities $ — $ 2,999 As of June 30, 2021 and December 31, 2020 the fair value of the Company’s debt approximates book value based on the variable terms. The Company’s financial results for the six months ended December 31, 2020 and nine months ended March 31, 2021 resulted in violations of certain of its financial covenants, as defined in the Company’s Credit Agreement. The Company has been actively discussing its results and the Company’s failure to meet its financial covenants with the Administrative Agent and entered into a forbearance agreement, providing a period commencing on April 9, 2021 and through and including June 15, 2021, during which the Company was able to borrow on its Revolver, subject to the terms and conditions to making a revolving credit advance, including availability, and the Lenders agreed, subject to the terms of the forbearance agreement, to forbear from enforcing their rights or seeking to collect payment of the Company’s debt or disposing of the collateral securing the debt. On June 14, 2021 the Company entered into the First Amendment to Forbearance Agreement, which among other things, extended the forbearance period from June 15, 2021 to February 28, 2022. During the extended period, the Company will be able to borrow under the Revolver, subject to availability and the satisfaction of certain other conditions. However, entering into a forbearance agreement will not alleviate the substantial doubt about the Company’s ability to continue as a going concern, please refer to Note 1 for further discussion. The Company intends to use the forbearance period to continue negotiations with the Lenders to enter into an amendment and waiver to cure the defaults. There can be no assurance that the Company will be able to enter into an amendment or waiver with the Lenders or if it enters into an amendment, what the terms, restrictions, and covenants of the amendment will contain. As a result of the default all debt subject to the Credit Agreement is classified as current maturities of long-term debt as of June 30, 2021. Credit Agreement On November 8, 2018, Unique Fabricating NA, Inc. (the “US Borrower”) and Unique-Intasco Canada, Inc. (the “CA Borrower” and together with the US Borrower, the “Borrowers”) and Citizens Bank, National Association (“Citizens”), acting as lender and Administrative Agent, and other lenders (collectively, the “Lenders”), entered into an Amended and Restated Credit Agreement (the “Credit Agreement”), which amended and restated the Original Credit Agreement entered into on April 29, 2016 (as amended, the “Original Credit Agreement”). The Amended and Restated Credit Agreement is a five year agreement and provided for borrowings up to an aggregate principal amount of $73.0 million. The Amended and Restated Credit Agreement, which is a senior secured credit facility, comprised of a revolving line of credit of up to $30.0 million (the “Revolver”) to the US Borrower, a $26.0 million principal amount term loan (the “US Term Loan”) to the US Borrower, a $12.0 million principal amount term loan (the “CA Term Loan”) to the CA Borrower, and a two year line to fund capital expenditures of up to $2.5 million through November 8, 2019 and $5.0 million thereafter through November 8, 2020 to the US Borrower (the “Capital Expenditure Line”). The Amended and Restated Credit Agreement has a maturity date for all borrowings of November 7, 2023. The Amended and Restated Credit Agreement requires quarterly principal payments for the US Term Loan, which commenced on December 31, 2018, of $337.5 thousand through September 30, 2020, $575.0 thousand thereafter through September 30, 2021, and $812.5 thousand thereafter through November 7, 2023 with a lump sum due at maturity. The Amended and Restated Credit Agreement requires quarterly principal payments for the CA Term Loan, which commenced on December 31, 2018, of $375.0 thousand with a lump sum due at maturity. The Capital Expenditure Line requires quarterly principal payments of 7.5% of the outstanding balance per annum beginning on December 31, 2019 through September 30, 2020, 10% per annum beginning December 31, 2020 through September 30, 2021, 12.5% per annum beginning December 31, 2021 and thereafter through November 7, 2023 with a lump sum due at maturity. In addition, the Amended and Restated Credit Agreement allows for increases in the principal amount of the Revolver and the US and CA Term Loans not to exceed a $10.0 million principal amount, in the aggregate, provided that before and after giving effect to the proposed increase (and any transactions to be consummated using proceeds of the increase), the total leverage and debt service coverage ratios do not exceed specified amounts. The Amended and Restated Credit Agreement also provides for the issuance of letters of credit with a face amount of up to a $2.0 million, in the aggregate, provided that any letter of credit that is issued will reduce availability under the Revolver. The Amended and Restated Credit Agreement contains customary negative covenants and requires that the Company comply with various financial covenants, including a total leverage ratio and debt service coverage ratio, as defined in the Amended and Restated Credit Agreement. Additionally, the US Term Loan and CA Term Loan each contains a clause, effective December 30, 2018, that requires an excess cash flow payment to be made to the lenders to reduce the US Term Loan and CA Term Loan if the Company’s cash flow exceeds certain thresholds as defined by the Amended and Restated Credit Agreement. Due to the impact of the COVID-19 pandemic on the Company and the global automotive industry, the Company anticipated that the EBITDA for the twelve months ended June 30, 2020 was likely to result in the Company not being in compliance with its financial covenants. In response to the anticipated impact of COVID-19, on April 23, 2020, the Borrowers entered into the Seventh Amendment (the “Seventh Amendment”) to the Credit Agreement. The Seventh Amendment, among other things, (i) permitted additional indebtedness in the form of unsecured loans authorized pursuant to and in compliance with the CARES Act under the Paycheck Protection Program of the U.S. Small Business Administration, in an aggregate amount not to exceed $6.0 million; (ii) deferred the June 30, 2020 principal payments on the US Term Loan, CA Term Loan, and Capital Expenditure Line, with the deferred principal amounts payable at the existing maturity dates; (iii) waived the requirement to test Maximum Total Leverage Ratio, Minimum Debt Service Coverage Ratio and Minimum Unadjusted Consolidated EBITDA for the fiscal quarter ended June 30, 2020; (iv) allowed the release of the lien on the Evansville, Indiana property and for the net cash proceeds from its sale to be applied against any outstanding balance on the Revolver, without permanently reducing the Revolving Credit Aggregate Commitment; (v) added a weekly requirement for the Borrowers to deliver a 13-week cash flow forecast until September 30, 2020; and (vi) added a 1.0% LIBOR Floor and 2.0% Base Rate Floor. On August 7, 2020, the Company entered into the Eighth Amendment (the “Eighth Amendment”) to the Amended and Restated Credit Agreement and Loan Documents, as amended. The Eighth Amendment, among other things, amended the definition of Consolidated EBITDA and made changes to the calculations of financial covenants. The definition of Consolidated EBITDA has been amended to include as an addition to Consolidated Net Income (i) costs and expenses incurred in connection with the Eighth Amendment not to exceed $175,000, (ii) restructuring expenses not to exceed $500,000 in any 12 month period, (iii) costs incurred with respect to the purchase and implementation of the ERP system not to exceed (A) $200,000 during each fiscal quarter in 2020 and (B) $100,000 during each fiscal quarter in 2021, and (iv) to the extent added in calculating Consolidated Net Income any portion of the PPP loan that has been forgiven and cancelled. The Eighth Amendment also amended the calculation of certain financial covenants based upon 12 month results to effectively exclude results of the quarter ended June 30, 2020. The calculation of Maximum Total Leverage Ratio has been amended, commencing with the quarter ended September 30, 2020 and through and including the quarter ended March 31, 2021, to annualize Consolidated EBITDA for the periods beginning July 1, 2020 through the date of calculation. The calculation of Minimum Debt Service Coverage Ratio for the quarters ended September 30, 2020, December 31, 2020 and March 31, 2021 are based upon results for one, two and three quarters, respectively. The Eighth Amendment further adds a Minimum Liquidity requirement to be calculated monthly through June 30, 2021 and Minimum Consolidated EBITDA for each measurement period, as defined, through June 30, 2021. The Eighth Amendment permitted distributions by US Borrower to the Parent to be declared and made only after December 31, 2021 provided certain conditions are satisfied. On April 9, 2021, the Company entered into a Forbearance Agreement, providing a period commencing through and including June 15, 2021, during which the Company was able to borrow on its Revolver, subject to the terms and conditions to making a revolving credit advance, including availability, and the Lenders agreed, subject to the terms of the forbearance agreement, to forbear from enforcing their rights or seeking to collect payment of the Company’s debt or disposing of the collateral securing the debt. On June 14, 2021, the Company entered into a First Amendment to Forbearance Agreement with respect to the Amended and Restated Credit Agreement, as amended, among the Borrowers, certain of their subsidiaries, with the Lenders. The First Amendment to the Forbearance Agreement extends the previously agreed to forbearance period from June 15, 2021 to February 28, 2022. During the extended period, the Company will continue to be able to borrow under the Revolver, subject to availability and the satisfaction of certain other conditions. The First Amendment suspends the testing of the Total Leverage Ratio and the Debt Service Ratio during the forbearance period, contains revised requirements for Minimum Liquidity and Minimum Consolidated EBITDA, as defined, for the monthly periods through and including February 28, 2022, makes changes to the calculations of financial covenants, establishes certain financial reporting requirements to the Lenders, provides an alternative to the LIBOR rate, and requires that the Company engage a financial advisor on or before June 25, 2021. The Company will be required to comply with the revised covenants contained in the First Amendment beginning with July 31, 2021. The Credit Agreement, as amended, bears interest at the Company’s election of either (i) the greater of the Prime Rate or the Federal Funds Effective Rate (the “Base Rate”) or (ii) the LIBOR rate, plus an applicable margin ranging from 1.75% to 3.25% per annum in the case of the Base Rate and 2.75% to 4.25% per annum in the case of the LIBOR rate, in each case, based on senior leverage ratio thresholds, measured quarterly, as increased by the Waiver and Fourth Amendment to the Amended and Restated Credit Agreement. As stated above, the Seventh Amendment added a 1.0% LIBOR Floor and 2.0% Base Rate Floor. The First Amendment to the Forbearance Agreement increased the per annum rate from 4.25% to 4.50% for the duration of the Forbearance Period. Furthermore, the First Amendment requires the calculation of Payment in Kind (“PIK”) additional interest of 0.5% on all outstanding debt subject to the Credit Agreement, which is payable on February 28, 2022 or earlier in the event of a Forbearance Termination event, as defined. As of June 30, 2021, $17.8 million was outstanding under the Revolver. This amount is gross of debt issuance costs which are further described in the next section. The Revolver had an effective interest rate of 5.50% percent per annum at June 30, 2021, and is secured by substantially all of the Company’s assets. At June 30, 2021, the maximum additional available borrowings under the Revolver was $6.7 million which includes a reduction for a $0.1 million letter of credit issued for the benefit of the landlord of one of the Company’s leased facilities. Paycheck Protection Program Note On April 24, 2020, the Company entered into a Promissory Note (“PPP Note”) for $6.0 million with Citizens Bank, National Association, (“PPP Lender”) pursuant to the U.S. Small Business Administration (“SBA”) Paycheck Protection Program under Title I of the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act passed by Congress and signed into law on March 27, 2020. On June 3, 2020, Congress passed the Paycheck Protection Program Flexibility Act of 2020 (the “PPP Flexibility Act”) and on June 5, 2020 it was signed into law. The PPP Flexibility Act modified certain provisions of the CARES Act. The PPP Note is unsecured, bears interest at 1.00% per annum, with principal and interest payments deferred until the earlier of (i) the PPP Lender receiving the forgiveness amount from the SBA or (ii) August 12, 2021. The PPP Note matures on April 24, 2022. The principal is payable in equal monthly installments, with interest, beginning on the first business day after the end of the deferment period. The PPP Note may be forgiven subject to the terms of the Paycheck Protection Program and PPP Flexibility Act. The Company applied for forgiveness in the fourth quarter of 2020 and is awaiting forgiveness determination from the U.S. Small Business Administration and our PPP Lender. Certain acts of the Company, including but not limited to: (i) the failure to pay any taxes when due, (ii) becoming the subject of a proceeding under any bankruptcy or insolvency law, (iii) making an assignment for the benefit of creditors, or (iv) reorganizing, merging, consolidating or otherwise changing ownership or business structure without PPP Lender’s prior written consent, are considered events of default which grant Lender the right to seek immediate payment of all amounts owing under the PPP Note. As of June 30, 2021, none of the circumstances listed above exist at the Company. On August 9, 2021, the Company received notification that the SBA approved the Company’s PPP Loan forgiveness application for the entire PPP Loan, including accrued interest. The forgiveness of the PPP Loan will be recognized during the Company’s third quarter ending September 30, 2021. Debt Issuance Costs Debt issuance costs represent legal, consulting, and other financial costs associated with debt financing and are reported netted against the related debt instrument. Amounts paid to or on behalf of lenders are presented as a debt discount and are also shown as a reduction of the associated debt instrument. Debt issuance costs on term debt are amortized using the straight line basis over the term of the related debt (which is immaterially different from the required effective interest method) while those related to revolving debt are amortized using a straight line basis over the term of the related debt. At June 30, 2021 and December 31, 2020, unamortized debt issuance costs were $0.3 million and $0.4 million, respectively, while amounts paid to or on behalf of lenders presented as unamortized debt discounts were $0.2 million and $0.3 million, respectively. Amortization expense of both debt issuance costs and debt discounts has been recognized as a component of interest expense in the amounts of $0.1 million and $0.1 million for the three and six months ended June 30, 2021, respectively, and $0.04 million and $0.1 million for the three and six months ended June 30, 2020, respectively. Covenant Compliance The Amended and Restated Credit agreement, as further amended and forbore by the Forbearance Agreement, as amended, contains the following financial covenants: Maximum Total Leverage Ratio The Total Leverage Ratio, as defined in the Credit Agreement, as amended, may not exceed (i) 3.75 to 1.00, with respect to the fiscal quarter ended as of September 30, 2020; (ii) 3.50 to 1.00, with respect to the fiscal quarter ended December 31, 2020; (iii) 3.25 to 1.00, with respect to the fiscal quarters ended March 31, 2021 and June 30, 2021; and (iv) 3.00 to 1.00, with respect to each fiscal quarter thereafter. For purposes of calculating the Total Leverage Ratio, “Consolidated EBITDA”, as defined, shall be determined (i) with respect to the fiscal quarter ended as of September 30, 2020, for the single fiscal quarter then ended, multiplied by 4,(ii) with respect to the fiscal quarter ended as of December 31, 2020, for the two fiscal quarters then ended, multiplied by 2, (iii) with respect to the fiscal quarter ended as of March 31, 2021, for the three fiscal quarters then ended, multiplied by 4/3, and (iv) with respect to each fiscal quarter thereafter, for the four fiscal quarters then ended. Also, for purposes of calculating the Total Leverage Ratio, the PPP Note is excluded from Total Debt for all periods until a determination of forgiveness is made. However, testing of the Total Leverage Ratio is suspended during the Forbearance Period through February 28, 2022. Minimum Debt Service Coverage Ratio The Debt Service Coverage Ratio may not be less than 1.20 to 1.00, to be measured, as of the end of each fiscal quarter. Notwithstanding anything to the contrary set forth in the definition of "Debt Service Coverage Ratio," such calculation shall be made (i) with respect to the fiscal quarter ended as of September 30 2020, for the single fiscal quarter then ended, (ii) with respect to the fiscal quarter ended as of December 31, 2020, for the two fiscal quarters then ended, (iii) with respect to the fiscal quarter ended as of March 31, 2021, for the three fiscal quarters then ended, and (iv) with respect to the last day of each fiscal quarter thereafter, for the four fiscal quarters then ended. However, testing of the Minimum Debt Service Coverage Ratio is suspended during the Forbearance Period through February 28, 2022. Minimum Liquidity The First Amendment to the Forbearance Agreement eliminated the Minimum Liquidity covenant of the Amended and Restated Credit Agreement and replaced it with the following: Date of Determination Minimum Liquidity July 31, 2021 $250,000 August 31, 2021 $250,000 September 30, 2021 $500,000 October 31, 2021 $1,000,000 November 30, 2021 $1,600,000 December 31, 2021 $1,600,000 January 31, 2022 $2,800,000 February 28, 2022 $3,200,000 Minimum Consolidated EBITDA The First Amendment to the Forbearance Agreement eliminated the Minimum Consolidated EBITDA covenant of the Amended and Restated Credit Agreement and replaced it with the following: Date of Determination Measurement Period Minimum Consolidated EBITDA July 31, 2021 Trailing 4 months $300,000 August 31, 2021 Trailing 5 months $1,300,000 September 30, 2021 Trailing 6 months $2,450,000 October 31, 2021 Trailing 7 months $3,400,000 November 30, 2021 Trailing 8 months $4,200,000 December 31, 2021 Trailing 9 months $5,025,000 January 31, 2022 Trailing 10 months $5,925,000 February 20, 2022 Trailing 11 months $6,900,000 Future Maturities Maturities on the Company’s Credit Agreement and other long term debt obligations for the remainder of the current fiscal year and future fiscal years are as follows: Future Maturities (dollars in thousands) 2021 $ 5,393 2022 49,634 2023 — Total 55,027 Discounts (235) Debt issuance costs (312) Total debt, net $ 54,480

Derivative Financial Instrument

Derivative Financial Instruments	6 Months Ended
	Jun. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Interest Rate Swap The Company holds a derivative financial instrument, in the form of an interest rate swap, as required by its Credit Agreement and Amended and Restated Credit Agreement, for the purpose of hedging certain identifiable transactions in order to mitigate risks relating to the variability of future earnings and cash flows caused by interest rate fluctuations. The Company has elected not to apply hedge accounting for financial reporting purposes. The interest rate swap is recognized in the accompanying condensed consolidated balance sheets at its fair value. Monthly settlement payments due on the interest rate swap and changes in its fair value are recognized currently in net income as interest expense in the accompanying condensed consolidated statements of operations. Effective November 30, 2018, as required under the Amended and Restated Credit Agreement, the Company entered into another interest rate swap that requires the Company to pay a fixed rate of 3.075% per annum while receiving a variable interest rate per annum based on the one month LIBOR for a net monthly settlement based on the notional amount in effect. The notional amount at the effective date was $5.0 million, which increased by $0.4 million each quarter until June 28, 2019 when the notional amount increased to $17.5 million due to the interest rate swap from 2016 expiring. Since June 28, 2019, the notional amount then decreased each quarter by $0.2 million until September 30, 2020 when the notional amount increased to $17.5 million due to the interest rate swap from 2017 expiring. The notional amount then decreases each quarter by $0.4 million until December 31, 2021, and then decreases each subsequent quarter by $0.6 million until it expires on November 8, 2023. At June 30, 2021, the fair value of all swaps was in a net liability position of $0.9 million and is included in other long term liabilities in the condensed consolidated balance sheets. The Company paid $0.1 million and $0.3 million in net monthly settlements with respect to the interest rate swaps for the three and six months ended June 30, 2021, respectively. At June 30, 2020, the fair value of the swaps was a net liability of $1.5 million, which was included in other long term liabilities in the condensed consolidated balance sheet. The Company paid $0.2 million and $1.0 million in net monthly settlements in respect to the interest rate swaps for the three and six months ended June 30, 2020, respectively. Both the change in fair value and the net monthly settlements were included in interest expense in the condensed consolidated statements of operations.

Restructuring

Restructuring	6 Months Ended
	Jun. 30, 2021
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring The Company's restructuring activities are undertaken as necessary to implement management's strategy and improve operating results. The restructuring activities generally relate to realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, either in the normal course of business or pursuant to specific restructuring programs. 2019 Restructurings Bryan Restructuring On November 7, 2019, the Company made the decision to close its manufacturing facility in Bryan, Ohio. Approximately 43 positions were eliminated as a result of the closure. The Company's decision resulted from its desire to streamline operations and to utilize some of the available excess capacity in other of our facilities. The Company moved existing Bryan production to its manufacturing facilities in Querétaro, Mexico and LaFayette, Georgia. The Company provided the affected employees severance pay, health benefits continuation, and job search assistance. The Company evaluated whether or not this closing met the criteria for discontinued operations and concluded that the closing did not meet the definition as it did not represent a strategic shift in the Company's operations and the Company will have continuing cash flows from the production being moved to other facilities within the Company. The restructuring activities described above were completed as of June 30, 2020. The Company has not incurred any restructuring costs in 2021. Evansville Restructuring On July 16, 2019, the Company made the decision to close its manufacturing facility in Evansville, Indiana. The Company ceased operations at the Evansville facility during the fourth quarter of 2019, and approximately 47 positions were eliminated as a result of the closure. The Company's decision resulted from its desire to streamline operations and to utilize some of the available excess capacity in other of our facilities. The Company moved existing Evansville production to its manufacturing facilities in LaFayette, Georgia, Auburn Hills, Michigan, and Louisville, Kentucky. The Company provided the affected employees severance pay, health benefits continuation, and job search assistance. The Company evaluated whether or not this closing met the criteria for discontinued operations and concluded that the closing did not meet the definition as it did not represent a strategic shift in the Company's operations and the Company will have continuing cash flows from the production being moved to other facilities within the Company. The restructuring activities described above were completed in 2020, the Company has not incurred any restructuring costs in 2021. The Company had $0.5 million and $0.7 million of remaining lease payments for a warehouse near the Evansville, Indiana facility as of June 30, 2021 and December 31, 2020, respectively. The Company has secured a sublease of roughly 11% of the facility. The table below summarizes the activity in the restructuring liability for the six months ended June 30, 2020: Employee Termination Benefits Liability Other Exit Costs Liability Total (dollars in thousands) Accrual balance at December 29, 2019 $ 438 $ 116 $ 554 Provision for estimated expenses to be incurred — 1,193 1,193 Payments made during the year and asset write offs 400 838 1,238 Accrual balance at June 30, 2020 $ 38 $ 470 $ 508

Stock Incentive Plans

Stock Incentive Plans	6 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock Incentive Plans	Stock Incentive Plans 2013 Stock Incentive Plan The Company’s board of directors approved a stock incentive plan (the “Plan”) in 2013. The Plan permits the Company to grant 495,000 non statutory or incentive stock options to the employees, directors and consultants of the Company. 495,000 shares of unissued common stock are reserved for the Plan. The board of directors has the authority to determine the participants to whom stock options shall be awarded as well as any restrictions to be placed upon the awards. The exercise price cannot be less than the fair value of the underlying shares at the time the stock options are issued and the maximum length of an award is ten years. On June 11, 2021, the compensation committee of the board of directors approved the issuance of 38,943 non statutory stock option awards to employees of the Company. All of the awards have an exercise price of $3.31 per share with a weighted average grant date fair value of $1.64 per share. These options vested immediately upon issuance. 2014 Omnibus Performance Award Plan In 2014, the board of directors and stockholders adopted the Unique Fabricating, Inc. 2014 Omnibus Performance Award Plan, or the 2014 Plan. The 2014 Plan provides for the grant of cash awards, stock options, stock appreciation rights, or SARs, shares of restricted stock and restricted stock units, or RSUs, performance shares and performance units. The 2014 Plan originally authorized the grant of awards relating to 250,000 shares of our common stock. In the event of any transaction that causes a change in capitalization, the compensation committee, such other committee administering the 2014 Plan or the board of directors will make such adjustments to the number of shares of common stock delivered, and the number and/or price of shares of common stock subject to outstanding awards granted under the 2014 Plan, as it deems appropriate and equitable to prevent dilution or enlargement of participants’ rights. An amendment approved in March of 2016 by our board of directors which was approved by our stockholders at our annual meeting of stockholders in June 2016, increased the number of shares authorized for grant of awards under the 2014 Plan to a total of 450,000 shares of our common stock. In July 2020, an additional amendment was approved at our annual meeting of stockholders, which increased the number of shares authorized for grant of awards under the 2014 Plan to a total of 700,000 shares of our common stock. The fair value of each of the option awards is estimated on the grant date using a Black Scholes option pricing model that uses the weighted average assumptions noted in the following tables. The expected volatility is based on the historical volatility of the stock of comparable companies. The expected term of the awards was estimated based on findings from academic studies investigating the average holding period for options for adjusted for the Company’s size and risk factors. The risk free rate for periods within the contractual life of the option is based on the United States Treasury yield curve in effect at the time of grant. On May 4, 2021, the compensation committee of the board of directors approved the issuance of 139,278 non statutory stock option awards to employees of the Company. All of the awards have an exercise price of $4.51 per share with a weighted average grant date fair value of $2.28 per share. 20% of these options vested immediately and the remainder vest in 20% tranches on each of May 4, 2022, 2023, 2024, and 2025, respectively. On June 11, 2021, the compensation committee of the board of directors approved the issuance of 59,254 non statutory stock option awards to employees of the Company. All of the awards have an exercise price of $3.31 per share with a weighted average grant date fair value of $1.64 per share. These options vested immediately upon issuance. A summary of option activity under both plans is presented below: Number of Weighted Weighted Average Remaining Aggregate Intrinsic Value (1) (dollars in thousands, except share data and exercise price) Outstanding at December 31, 2020 726,500 $ 4.53 7.2 $ 1,484 Granted 237,475 $ 4.01 4.3 Exercised — $ — 0 Forfeited or expired 15,000 $ 12.50 0 0 Outstanding at June 30, 2021 948,975 $ 4.27 7.6 $ 444 Vested and exercisable at June 30, 2021 454,553 $ 5.25 6.1 $ 169 ———————————— (1) The aggregate intrinsic value above is obtained by subtracting the exercise price from the estimated fair value of the underlying shares and multiplying this result by the related number of options outstanding and exercisable as of the period end date. There is no intrinsic value if the exercise price exceeds the fair value of the underlying shares. The estimated fair value of the shares is based on the closing price of the stock of $3.70 as of June 30, 2021 and $5.50 as of December 31, 2020. The Company recorded stock-based compensation expense of $256 thousand and $283 thousand for the three and six months ended June 30, 2021, respectively, and $32 thousand and $55 thousand for the three and six months ended June 30, 2020, respectively. Stock compensation expense is included in the condensed consolidated statements of operations, as a component of sales, general and administrative expenses. The income tax (expense) benefit related to share based compensation expense was immaterial for all periods presented. As of June 30, 2021, there was $689 thousand of total unrecognized compensation cost related to non-vested stock option awards under the plans. That cost is expected to be recognized over a weighted average period of 4.1 years.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For interim tax reporting we estimate our annual effective tax rate and apply it to our year to date income before income taxes. The tax effects of unusual or infrequently occurring items, including changes in judgment about valuation allowances and the effect of changes in tax laws or rates, are reported in the interim period in which they occur, if applicable. Income tax (benefit) expense for the three and six months ended June 30, 2021 was $0.3 million and $0.7 million, respectively, compared to $(1.1) million and $(1.7) million for the three and six months ended June 30, 2020, respectively. During the three and six months ended June 30, 2021, the effective tax rate was 13% and 26%, respectively. The differences between the effective tax rates and the statutory rate of 21% were primarily due to valuation allowance in the U.S. and earnings in Mexico and Canada, which both have higher statutory income tax rates than the U.S.

Leases

Leases	6 Months Ended
	Jun. 30, 2021
Leases [Abstract]
Leases	Leases The Company records a right-of-use (“ROU”) asset and lease liability for substantially all leases for which it is a lessee, in accordance with ASC 842. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. The Company has no significant lease agreements in place for which the Company is a lessor. At inception of a contract, the Company considers all relevant facts and circumstances to assess whether or not the contract represents a lease by determining whether or not the contract conveys the right to control the use of an identified asset, either explicit or implicit, for a period of time in exchange for consideration. The Company leases certain industrial spaces, office space, land, and equipment. Some leases include one or more options to renew, with renewal terms that can extend the lease term from generally one during the three and six months ended June 30, 2021 were immaterial. As of June 30, 2021, leases that the Company has signed but have not yet commenced are immaterial. Leased assets and liabilities included within the condensed consolidated balance sheets consist of the following: Classification June 30, 2021 (dollars in thousands) Right-of-Use-Assets Operating Operating leases $ 9,274 Liabilities Current Operating Other accrued liabilities $ 1,964 Non-current Operating Other liabilities 8,168 Total lease liabilities $ 10,132 Lease costs included in the condensed consolidated statements of operations consist of the following: Classification Six Months Ended June 30, 2021 (dollars in thousands) Lease cost Cost of sales, selling expenses and general and administrative expense $ 1,307 Maturity of the Company’s lease liabilities as of June 30, 2021 is as follows: Lease Liability Maturities (dollars in thousands) 2021 (remainder) $ 1,446 2022 2,058 2023 1,381 2024 1,296 2025 1,288 Thereafter 5,413 Total lease payments 12,882 Less: interest 2,751 Present value of lease payments $ 10,132 As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Remaining lease term and discount rates are as follows: June 30, 2021 Weighted average remaining lease term (years) 7.0 Weighted average discount rate 6.5 % Lease costs included in the condensed consolidated statements of cash flows are as follows: Six Months Ended June 30, 2021 (dollars in thousands) Cash paid for amounts included in the measurement of lease liabilities Operating cash outflows from operating leases $ 1,531

Retirement Plans

Retirement Plans	6 Months Ended
	Jun. 30, 2021
Retirement Benefits [Abstract]
Retirement Plans	Retirement PlansThe Company maintains a defined contribution plan covering certain full time salaried employees. Employees can make elective contributions to the plan. The Company contributes a match on 100% of an employee’s contribution up to the first 3% of each employee’s total compensation and 50% for the next 2% of each employee’s total compensation. In addition, the Company, at the discretion of the board of directors, may make additional contributions to the plan on behalf of the plan participants. The Company contributed $0.1 million and $0.2 million for the three and six months ended June 30, 2021 and $0.1 million and $0.2 million for the three and six months ended June 30, 2020.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Effective March 18, 2013, the Company is a party to a management agreement with a firm related to several stockholders. The agreement initially provided for annual management fees of $300 thousand and additional fees for assistance provided with acquisitions. Effective upon completion of the Company's initial public offering, the agreement was amended to reduce the annual management fee by an amount equal to the amount, if any, of annual cash retainers and equity awards received as compensation for service on the board of directors to any person who is a related person of Taglich Private Equity, LLC or Taglich Brothers, Inc. The Company incurred management fees of $56 thousand for the three months ended March 31, 2021, however, the Forbearance Agreement suspended any further management fee payments until the expiration of the Forbearance Period on February 28, 2022. The Company incurred management fees of $56 thousand and $110 thousand for the three and six months ended June 30, 2020, respectively. The management agreement had an initial term of five years, expiring on March 18, 2020, and renews automatically annually for additional one year terms. The current term expires on March 18, 2022. The agreement also will terminate on the date that the Taglich Founding Investors or Taglich Equity Investors, each as defined, no longer also collectively own 50% of the equity securities owned by either of them on March 18, 2013. Beginning in February 2021, the Company began utilizing the services of Engauge Workforce Solutions LLC (“Engauge”), a manufacturing and distribution staffing agency. Ms. Kim Korth, a member of the Company’s Board of Directors, is also the Managing Director of Engauge. In March 2021, the Company entered into an agreement with Engauge for its services. The agreement is for an initial term of 12 months and will continue on a month-to-month basis after the initial term. The Company may terminate the agreement, without penalty, following the initial term with 60 days written notice. The Company has incurred fees for Engauge’s services through June 30, 2021 of $228 thousand.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Financial instruments consist of cash equivalents, accounts receivable, accounts payable and debt. The carrying amount of all significant financial instruments approximates fair value due to either the short maturity or the existence of variable interest rates that approximate prevailing market rates. Accounting standards require certain other items be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value. Fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. Level 2 inputs may include quoted prices for similar items in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related item. Level 3 fair value measurements are based primarily on management’s own estimates using inputs such as pricing models, discounted cash flow methodologies or similar techniques taking into account the characteristics of the item. In instances whereby inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each item. The Company measures its interest rate swaps at fair value on a recurring basis based primarily on Level 2 inputs using an income model based on disparity between variance and fixed interest rates, the scheduled balance of principal outstanding, yield curves and other information readily available in the market. Please refer to Note 7 for more information on the Company’s interest rate swap.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic earnings per share is computed by dividing the net income by the weighted-average number of shares outstanding during the period. Diluted earnings per share is computed giving effect to all potentially weighted average dilutive shares including stock options and warrants. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method. The following table sets forth the reconciliation of the numerator and the denominator of basic and diluted loss per share for the three and six months ended June 30, 2021 and 2020: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 (dollars in thousands, except per share amounts) Numerator: Net income (loss) $ (2,509) $ (4,322) $ (3,578) $ (6,624) Denominator: Weighted average shares outstanding, basic 9,779,147 9,779,147 9,779,147 9,779,147 Dilutive effect of stock-based awards — — — — Weighted average share outstanding, diluted 9,779,147 9,779,147 9,779,147 9,779,147 Basic loss per share $ (0.26) $ (0.44) $ (0.37) $ (0.68) Diluted loss per share $ (0.26) $ (0.44) $ (0.37) $ (0.68) The effect of certain common stock equivalents were excluded from the computation of weighted average diluted shares outstanding for the three months and six months ended June 30, 2020, as inclusion would have resulted in anti-dilution. A summary of these anti-dilutive common stock equivalents is provided in the table below: Six Months Ended June 30, 2021 2020 Number of options 948,975 611,480 Exercise price of options $2.36 - $12.58 $2.36 - $12.58 Warrants (1) 142,185 Exercise price of warrants $3.33 - $11.88 _________________________________

Contingencies

Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Contingencies	ContingenciesThe Company is engaged from time to time in legal matters and proceedings arising out of its normal course of business. The Company establishes a liability related to its legal proceedings and claims when it has determined that it is probable that the Company has incurred a liability and the related amount can be reasonably estimated. If the Company determines that an obligation is reasonably possible, the Company will, if material, disclose the nature of the loss contingency and the estimated range of possible loss, or include a statement that no estimate of loss can be made. While uncertainties are inherent in the final outcome of such matters, the Company believes that there are no pending proceedings in which the Company is currently involved that will have a material effect on its financial position, results of operations or cash flow.

Nature of Business and Basis _2

Nature of Business and Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company’s condensed consolidated financial statements have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements contain all material adjustments (consisting only of normal recurring adjustments) necessary to present fairly the consolidated financial position of the Company, its results of operations, and its cash flows. The interim results for the periods presented may not be indicative of the Company's actual annual results. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Going Concern The Company’s consolidated financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company’s financial results for the six months ended December 31, 2020, and the nine months ended March 31, 2021, resulted in violations of certain of its financial covenants, as defined in the Company’s Credit Agreement ( Note 6 ). As a result of the default, the lenders may accelerate the maturity of the debt and accordingly all debt subject to the Credit Agreement, totaling $48.5 million, has been classified as current as of June 30, 2021. On April 9, 2021, the Company and its lenders entered into a forbearance agreement through and including June 15, 2021, during which the Company was able to borrow on its revolving line of credit, subject to availability and the satisfaction of certain other conditions, and the Lenders agreed not to accelerate the maturity of the Company’s debt during the forbearance period. On June 14, 2021 the Company entered into the First Amendment to Forbearance Agreement, which among other things, extended the forbearance period from June 15, 2021 to February 28, 2022, suspended the testing of the Total Leverage Ratio and the Debt Service Ratio during the forbearance period and included revised requirements for Minimum Liquidity and Minimum Consolidated EBITDA, as defined, for the monthly periods through and including February 28, 2022, beginning with the month ending July 31, 2021. During the extended period, the Company will continue to be able to borrow under the revolving line of credit, subject to availability and the satisfaction of certain other conditions, including compliance with financial covenants. Please refer to Note 6 Long-term Debt for more information. However, the Company does not have sufficient cash and cash equivalents on hand or other available sources of liquidity to repay outstanding debt under the Credit Agreement at expiration of the Forbearance Agreement, as amended. These events and conditions raise substantial doubt about the Company’s ability to continue as a going concern for the one-year period following the date that these financial statements are issued. In response to these conditions, the Company has been actively pursuing with Citizens Bank, National Association (“Citizens”), acting as lender and Administrative Agent, and the other lenders (collectively, the “Lenders”) a waiver of the violations at December 31, 2020 and March 31, 2021 or amendment of its financial covenants prior to expiration of the Forbearance Agreement as amended. However, these discussions have not been finalized and are not within the Company’s control, and therefore cannot be deemed probable. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern. As described in Note 6 to these condensed consolidated financial statements, the Company’s Forbearance Agreement, as amended, contains certain financial covenants with which we are required to comply, commencing with the four-month period ending July 31, 2021, through and including the eleven-month period ending February 28, 2022. There cannot be any assurance that the Company will be able to comply with these covenants contained in the Forbearance Agreement, including as soon as with respect to the first measurement period, given the industry-wide and other challenges that the Company is currently facing, as described elsewhere herein or that our lenders would waive a default if that were to occur. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.
New Accounting Pronouncements	In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-13, “Financial Instruments - Credit Losses,” which introduced new guidance for an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Instruments in scope include loans, held-to-maturity debt securities, and net investments in leases as well as reinsurance and trade receivables. In November 2018, the FASB issued ASU 2018-19, which clarifies that operating lease receivables are outside the scope of the new standard. In November 2019, the FASB issued ASU 2019-10, which established the effective date of the new standard for smaller reporting companies as fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact, if any, the adoption of the new credit losses model will have on its financial statements. In February 2016, the FASB issued ASU 2016-2, Leases (Topic 842). This update requires lessees to recognize on the balance sheet assets and liabilities for the rights and obligations created by leases of greater than twelve months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. We have identified our existing lease contracts and calculated the right of use assets, which are reflected in Other Assets on the Condensed Consolidated Balance Sheets, and lease liabilities, which are reflected in the Other Accrued Liabilities on the Condensed Consolidated Balance Sheets. This guidance was effective for the Company as of January 1, 2020. Adoption of the new standard resulted in the recording of right-of-use assets and liabilities of $12.1 million and $12.8 million, respectively, as of January 1, 2020. The FASB has issued further ASUs related to the standard providing an optional transition method allowing entities to not recast comparative periods. The Company elected the practical expedients upon transition that retained the lease classification and initial direct costs for any leases that exist prior to adoption of the standard. The Company has approximately $10.1 million of non-cancelable future rental obligations as of June 30, 2021, as shown in Note 11. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740). The guidance simplifies accounting for income taxes by removing certain exceptions. This new guidance is effective for fiscal years beginning after December 15, 2020 for public companies. The Company adopted this guidance on a prospective basis and there was no material impact. In March 2020, the FASB issued ASU No. 2020-04 “Reference Rate Reform”. The ASU provides temporary optional guidance to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or any other reference rate expected to be discontinued. The ASU is intended to help stakeholders during the global market-wide reference rate transition period. Therefore, it will be in effect for a limited time through December 31, 2022. The Company is currently assessing which contracts may be affected.
Revenue Recognition	Revenue is recognized by the Company once all performance obligations under the terms of a contract with a Company's customer is satisfied. Generally this occurs with the transfer of control to a customer of its transportation, appliance, and other products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring its products. The Company’s payment terms vary by the type and location of its customers and the products offered. The term between invoicing and when payment is due is not significant. In general for sales arrangements, the Company deems control to transfer at a single point in time and recognizes revenue when it ships products from its manufacturing facilities to its customers. Once a product has shipped, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to transfer upon shipment because the Company has a present right to payment at that time, the customer has legal title to the asset, and the customer has significant risks and rewards of ownership of the asset. Contract Balances
Fair Value Measurement	Financial instruments consist of cash equivalents, accounts receivable, accounts payable and debt. The carrying amount of all significant financial instruments approximates fair value due to either the short maturity or the existence of variable interest rates that approximate prevailing market rates. Accounting standards require certain other items be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value. Fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. Level 2 inputs may include quoted prices for similar items in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related item. Level 3 fair value measurements are based primarily on management’s own estimates using inputs such as pricing models, discounted cash flow methodologies or similar techniques taking into account the characteristics of the item. In instances whereby inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each item. The Company measures its interest rate swaps at fair value on a recurring basis based primarily on Level 2 inputs using an income model based on disparity between variance and fixed interest rates, the scheduled balance of principal outstanding, yield curves and other information readily available in the market. Please refer to Note 7 for more information on the Company’s interest rate swap.

Nature of Business and Basis _3

Nature of Business and Basis of Presentation (Tables)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Schedules of Concentration of Risk	The following table presents the Company's sales directly to General Motors Company (“GM”), Yanfeng Automotive Interiors, Stellantis N.V. (formerly Fiat Chrysler Automobiles), and Ford Motor Company (“Ford”) as a percentage of total net sales: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 General Motors Company 13 % 8 % 10 % 9 % Yanfeng Automotive Interiors 7 % 5 % 7 % 7 % Stellantis N.V. 6 % 4 % 6 % 5 % Ford Motor Company 2 % 4 % 4 % 5 % Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Mexico 26 % 20 % 24 % 22 % Canada 10 % 12 % 10 % 9 % The following table presents the percentage of the Company's total net sales represented by net sales from operations located in Mexico and Canada: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Mexico 26 % 17 % 25 % 21 % Canada 10 % 9 % 10 % 8 %

Revenues (Tables)

Revenues (Tables)	6 Months Ended
	Jun. 30, 2021
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table presents the Company's net sales disaggregated by major sales channel for the three and six months ended June 30, 2021 and 2020: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 (dollars in thousands) Net Sales Transportation $ 27,373 $ 11,290 $ 58,617 $ 42,986 Appliance 3,008 2,132 6,143 4,912 Other 515 1,553 934 1,738 Total $ 30,896 $ 14,975 $ 65,694 $ 49,636

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Jun. 30, 2021
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventories consist of the following: June 30, December 31, (dollars in thousands) Raw materials $ 9,759 $ 7,366 Work in progress 1,172 1,225 Finished goods 4,369 3,360 Total inventory $ 15,300 $ 11,951

Property, Plant, and Equipmen_2

Property, Plant, and Equipment, Net (Tables)	6 Months Ended
	Jun. 30, 2021
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant, and equipment, net consists of the following: June 30, December 31, Depreciable (dollars in thousands) Land $ 538 $ 538 Buildings 6,923 6,923 23 – 40 Shop equipment 25,012 23,436 7 – 10 Leasehold improvements 1,269 1,245 3 – 10 Office equipment 2,884 2,331 3 – 7 Mobile equipment 50 152 3 Construction in progress 2,376 2,315 Total cost 39,052 36,940 Less: Accumulated depreciation 15,952 14,557 Net property, plant, and equipment, net $ 23,100 $ 22,383

Long-term Debt (Tables)

Long-term Debt (Tables)	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Schedule of Long-Term Debt	The Company’s long-term debt consists of the following: June 30, December 31, (dollars in thousands) U.S. Small Business Administration Paycheck Protection Program loan (PPP Note), payable in equal monthly installments on the first day after the deferment period. The PPP Note is unsecured and bears interest at 1% per annum. The PPP Note may be forgiven subject to the terms of the Paycheck Protection Program. $ 5,999 $ 5,999 US Term Loan, payable to lenders in quarterly installments of $0.6 million through September 30, 2021 and $0.8 million through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at June 30, 2021. At June 30, 2021, the balance of the US Term Loan is presented net of a debt discount of $0.2 million from costs paid to or on behalf of the lenders. 21,665 22,768 CA Term Loan, payable to lenders in quarterly installments of $0.4 million through November 7, 2023, with a lump sum due at maturity. The effective interest rate was 5.5% per annum at June 30, 2021. At June 30, 2021, the balance of the CA Term Loan is presented net of a debt discount of $0.1 million from costs paid to or on behalf of the lenders. 8,145 8,876 Capital expenditure line payable to lenders in quarterly installments of 10% per annum through September 30, 2021, and 12.5% per annum through November 7, 2023 with a lump sum due at maturity. The effective interest rate was 5.5% per annum at June 30, 2021. 1,134 1,220 Total debt excluding Revolver 36,943 38,863 Less current maturities 36,943 35,864 Long-term debt – Less current maturities $ — $ 2,999
Schedule of Minimum Borrowers Liquidity	The First Amendment to the Forbearance Agreement eliminated the Minimum Liquidity covenant of the Amended and Restated Credit Agreement and replaced it with the following: Date of Determination Minimum Liquidity July 31, 2021 $250,000 August 31, 2021 $250,000 September 30, 2021 $500,000 October 31, 2021 $1,000,000 November 30, 2021 $1,600,000 December 31, 2021 $1,600,000 January 31, 2022 $2,800,000 February 28, 2022 $3,200,000
Summary of Minimum Consolidated EBITDA	The First Amendment to the Forbearance Agreement eliminated the Minimum Consolidated EBITDA covenant of the Amended and Restated Credit Agreement and replaced it with the following: Date of Determination Measurement Period Minimum Consolidated EBITDA July 31, 2021 Trailing 4 months $300,000 August 31, 2021 Trailing 5 months $1,300,000 September 30, 2021 Trailing 6 months $2,450,000 October 31, 2021 Trailing 7 months $3,400,000 November 30, 2021 Trailing 8 months $4,200,000 December 31, 2021 Trailing 9 months $5,025,000 January 31, 2022 Trailing 10 months $5,925,000 February 20, 2022 Trailing 11 months $6,900,000
Schedule of Maturities of Long-Term Debt	Maturities on the Company’s Credit Agreement and other long term debt obligations for the remainder of the current fiscal year and future fiscal years are as follows: Future Maturities (dollars in thousands) 2021 $ 5,393 2022 49,634 2023 — Total 55,027 Discounts (235) Debt issuance costs (312) Total debt, net $ 54,480

Restructuring (Tables)

Restructuring (Tables)	6 Months Ended
	Jun. 30, 2021
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Liability	The table below summarizes the activity in the restructuring liability for the six months ended June 30, 2020: Employee Termination Benefits Liability Other Exit Costs Liability Total (dollars in thousands) Accrual balance at December 29, 2019 $ 438 $ 116 $ 554 Provision for estimated expenses to be incurred — 1,193 1,193 Payments made during the year and asset write offs 400 838 1,238 Accrual balance at June 30, 2020 $ 38 $ 470 $ 508

Stock Incentive Plans (Tables)

Stock Incentive Plans (Tables)	6 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Stock Options and Stock Appreciation Rights Award Activity	A summary of option activity under both plans is presented below: Number of Weighted Weighted Average Remaining Aggregate Intrinsic Value (1) (dollars in thousands, except share data and exercise price) Outstanding at December 31, 2020 726,500 $ 4.53 7.2 $ 1,484 Granted 237,475 $ 4.01 4.3 Exercised — $ — 0 Forfeited or expired 15,000 $ 12.50 0 0 Outstanding at June 30, 2021 948,975 $ 4.27 7.6 $ 444 Vested and exercisable at June 30, 2021 454,553 $ 5.25 6.1 $ 169 ————————————

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2021
Leases [Abstract]
Balance Sheet and Weighted-Average Lease Information	Leased assets and liabilities included within the condensed consolidated balance sheets consist of the following: Classification June 30, 2021 (dollars in thousands) Right-of-Use-Assets Operating Operating leases $ 9,274 Liabilities Current Operating Other accrued liabilities $ 1,964 Non-current Operating Other liabilities 8,168 Total lease liabilities $ 10,132 June 30, 2021 Weighted average remaining lease term (years) 7.0 Weighted average discount rate 6.5 %
Lease Cost Information	Lease costs included in the condensed consolidated statements of operations consist of the following: Classification Six Months Ended June 30, 2021 (dollars in thousands) Lease cost Cost of sales, selling expenses and general and administrative expense $ 1,307 Lease costs included in the condensed consolidated statements of cash flows are as follows: Six Months Ended June 30, 2021 (dollars in thousands) Cash paid for amounts included in the measurement of lease liabilities Operating cash outflows from operating leases $ 1,531
Lease Maturity	Maturity of the Company’s lease liabilities as of June 30, 2021 is as follows: Lease Liability Maturities (dollars in thousands) 2021 (remainder) $ 1,446 2022 2,058 2023 1,381 2024 1,296 2025 1,288 Thereafter 5,413 Total lease payments 12,882 Less: interest 2,751 Present value of lease payments $ 10,132

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the reconciliation of the numerator and the denominator of basic and diluted loss per share for the three and six months ended June 30, 2021 and 2020: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 (dollars in thousands, except per share amounts) Numerator: Net income (loss) $ (2,509) $ (4,322) $ (3,578) $ (6,624) Denominator: Weighted average shares outstanding, basic 9,779,147 9,779,147 9,779,147 9,779,147 Dilutive effect of stock-based awards — — — — Weighted average share outstanding, diluted 9,779,147 9,779,147 9,779,147 9,779,147 Basic loss per share $ (0.26) $ (0.44) $ (0.37) $ (0.68) Diluted loss per share $ (0.26) $ (0.44) $ (0.37) $ (0.68)
Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share	A summary of these anti-dilutive common stock equivalents is provided in the table below: Six Months Ended June 30, 2021 2020 Number of options 948,975 611,480 Exercise price of options $2.36 - $12.58 $2.36 - $12.58 Warrants (1) 142,185 Exercise price of warrants $3.33 - $11.88 _________________________________

Nature of Business and Basis _4

Nature of Business and Basis of Presentation - Narrative (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)segment	Dec. 31, 2020USD ($)
Concentration Risk [Line Items]
Number of reportable segments | segment	1
Revolver, current maturities	$ 17,537	$ 11,494
Credit agreement
Concentration Risk [Line Items]
Revolver, current maturities	$ 48,500
Labor force concentration risk | Workforce Subject to Collective Bargaining Arrangements | Collective Bargaining Arrangements Expiring August 2022
Concentration Risk [Line Items]
Concentration risk (percentage)	33.00%
Labor force concentration risk | Workforce Subject to Collective Bargaining Arrangements | Collective Bargaining Arrangements Expiring February 2023
Concentration Risk [Line Items]
Concentration risk (percentage)	13.00%

Nature of Business and Basis _5

Nature of Business and Basis of Presentation - Customers' Net Sales as a Percentage of Total Net Sales (Details) - Sales revenue, net - Customer concentration risk	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
General Motors Company
Product Information [Line Items]
Concentration risk (percentage)	13.00%	8.00%	10.00%	9.00%
Yanfeng Automotive Interiors
Product Information [Line Items]
Concentration risk (percentage)	7.00%	5.00%	7.00%	7.00%
Stellantis N.V.
Product Information [Line Items]
Concentration risk (percentage)	6.00%	4.00%	6.00%	5.00%
Ford Motor Company
Product Information [Line Items]
Concentration risk (percentage)	2.00%	4.00%	4.00%	5.00%

Nature of Business and Basis _6

Nature of Business and Basis of Presentation - Production in Foreign Markets (Details) - Geographic Concentration Risk	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Mexico | Cost of Goods and Service Benchmark
Product Information [Line Items]
Concentration risk (percentage)	26.00%	20.00%	24.00%	22.00%
Mexico | Sales revenue, net
Product Information [Line Items]
Concentration risk (percentage)	26.00%	17.00%	25.00%	21.00%
Canada | Cost of Goods and Service Benchmark
Product Information [Line Items]
Concentration risk (percentage)	10.00%	12.00%	10.00%	9.00%
Canada | Sales revenue, net
Product Information [Line Items]
Concentration risk (percentage)	10.00%	9.00%	10.00%	8.00%

New Accounting Pronouncements (

New Accounting Pronouncements (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020	Jan. 01, 2020
Lessee, Lease, Description [Line Items]
Operating	$ 9,274	$ 10,415
Present value of lease payments	$ 10,132
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Operating			$ 12,100
Present value of lease payments			$ 12,800

Revenues (Details)

Revenues (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Net sales	$ 30,896	$ 14,975	$ 65,694	$ 49,636
Transportation
Disaggregation of Revenue [Line Items]
Net sales	27,373	11,290	58,617	42,986
Appliance
Disaggregation of Revenue [Line Items]
Net sales	3,008	2,132	6,143	4,912
Other
Disaggregation of Revenue [Line Items]
Net sales	$ 515	$ 1,553	$ 934	$ 1,738

Inventory - Schedule of Invento

Inventory - Schedule of Inventory (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials	$ 9,759	$ 7,366
Work in progress	1,172	1,225
Finished goods	4,369	3,360
Total inventory	$ 15,300	$ 11,951

Inventory - Additional Informat

Inventory - Additional Information (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Inventory [Line Items]
Allowance for obsolete inventory	$ 900	$ 400
Inventory, net	15,300	11,951
Mexico
Inventory [Line Items]
Inventory, net	3,800	3,100
Canada
Inventory [Line Items]
Inventory, net	$ 1,100	$ 1,100

Property, Plant, and Equipmen_3

Property, Plant, and Equipment, Net - Schedule of Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Total cost	$ 39,052	$ 36,940
Less: Accumulated depreciation	15,952	14,557
Net property, plant, and equipment, net	23,100	22,383
Land
Property, Plant and Equipment [Line Items]
Total cost	538	538
Buildings
Property, Plant and Equipment [Line Items]
Total cost	$ 6,923	6,923
Buildings | Minimum
Property, Plant and Equipment [Line Items]
Depreciable life, years	23 years
Buildings | Maximum
Property, Plant and Equipment [Line Items]
Depreciable life, years	40 years
Shop equipment
Property, Plant and Equipment [Line Items]
Total cost	$ 25,012	23,436
Shop equipment | Minimum
Property, Plant and Equipment [Line Items]
Depreciable life, years	7 years
Shop equipment | Maximum
Property, Plant and Equipment [Line Items]
Depreciable life, years	10 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total cost	$ 1,269	1,245
Leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Depreciable life, years	3 years
Leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Depreciable life, years	10 years
Office equipment
Property, Plant and Equipment [Line Items]
Total cost	$ 2,884	2,331
Office equipment | Minimum
Property, Plant and Equipment [Line Items]
Depreciable life, years	3 years
Office equipment | Maximum
Property, Plant and Equipment [Line Items]
Depreciable life, years	7 years
Mobile equipment
Property, Plant and Equipment [Line Items]
Total cost	$ 50	152
Depreciable life, years	3 years
Construction in progress
Property, Plant and Equipment [Line Items]
Total cost	$ 2,376	$ 2,315

Property, Plant, and Equipmen_4

Property, Plant, and Equipment, Net - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 800	$ 700	$ 1,500	$ 1,400
Property, plant, and equipment, net	23,100		23,100		$ 22,383
Mexico
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, net	3,800		3,800		3,700
Canada
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, net	$ 400		$ 400		$ 400

Long-term Debt - Schedule of Lo

Long-term Debt - Schedule of Long-Term Debt (Details) - USD ($)	6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Unamortized discount	$ 235,000	$ 300,000
Total debt excluding Revolver	36,943,000	38,863,000
Less current maturities	36,943,000	35,864,000
Long-term debt – Less current maturities	$ 0	2,999,000
Line of credit | PPP under CARES Act | Secured debt
Debt Instrument [Line Items]
Effective interest rate	1.00%
Total debt excluding Revolver	$ 5,999,000	5,999,000
Line of credit | New US Term Loan | Secured debt
Debt Instrument [Line Items]
Effective interest rate	5.50%
Unamortized discount	$ 200,000
Total debt excluding Revolver	21,665,000	22,768,000
Line of credit | New US Term Loan | Secured debt | October 1, 2020 Through September 30, 2021
Debt Instrument [Line Items]
Principal payment	575,000
Line of credit | New US Term Loan | Secured debt | October 1, 2021 Through November 7, 2023
Debt Instrument [Line Items]
Principal payment	$ 812,500
Line of credit | CA term loan | Secured debt
Debt Instrument [Line Items]
Effective interest rate	5.50%
Unamortized discount	$ 100,000
Total debt excluding Revolver	8,145,000	8,876,000
Line of credit | CA term loan | Secured debt | October 1, 2021 Through November 7, 2023
Debt Instrument [Line Items]
Principal payment	$ 400,000
Line of credit | Capital expenditure line
Debt Instrument [Line Items]
Effective interest rate	5.50%
Total debt excluding Revolver	$ 1,134,000	$ 1,220,000
Line of credit | Capital expenditure line | October 1, 2020 Through September 30, 2021
Debt Instrument [Line Items]
Percent of principal payment	10.00%
Line of credit | Capital expenditure line | October 1, 2021 Through November 7, 2023
Debt Instrument [Line Items]
Percent of principal payment	12.50%

Long-term Debt - Additional Inf

Long-term Debt - Additional Information (Details) - USD ($)	Jun. 14, 2021	Apr. 23, 2020	Nov. 08, 2018	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Aug. 07, 2020	Apr. 24, 2020
Debt Instrument [Line Items]
Outstanding principal amount				$ 36,943,000		$ 36,943,000		$ 38,863,000
Promissory note				55,027,000		55,027,000
Debt issuance cost				300,000		300,000		400,000
Unamortized discount				235,000		235,000		300,000
Amortization expense of debt issuance costs				100,000	$ 40,000	100,000	$ 100,000
Promissory Note | PPP under CARES Act
Debt Instrument [Line Items]
Promissory note										$ 6,000,000
Interest										1.00%
Credit agreement | Line of credit | Secured debt
Debt Instrument [Line Items]
Maximum increase to principal amount						10,000,000
Credit agreement | Line of credit | Secured debt | Base Rate | Minimum
Debt Instrument [Line Items]
Basis spread on variable rate			1.75%
Credit agreement | Line of credit | Secured debt | Base Rate | Maximum
Debt Instrument [Line Items]
Basis spread on variable rate			3.25%
Credit agreement | Line of credit | Secured debt | LIBOR | Minimum
Debt Instrument [Line Items]
Basis spread on variable rate			2.75%
Credit agreement | Line of credit | Secured debt | LIBOR | Maximum
Debt Instrument [Line Items]
Basis spread on variable rate			4.25%
Credit agreement | Letter of credit | Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity				2,000,000		2,000,000
New revolver | Line of credit | Revolving credit facility
Debt Instrument [Line Items]
Maximum increase to principal amount						6,700,000
Line of credit				$ 17,800,000		$ 17,800,000
Effective interest rate				5.50%		5.50%
Letters of credit outstanding, amount				$ 100,000		$ 100,000
CA term loan | Line of credit | Secured debt
Debt Instrument [Line Items]
Outstanding principal amount				$ 8,145,000		$ 8,145,000		8,876,000
Effective interest rate				5.50%		5.50%
Unamortized discount				$ 100,000		$ 100,000
Amended And Restated Credit Agreement
Debt Instrument [Line Items]
Debt instrument, covenant debt costs maximum									$ 175,000
Debt instrument, covenant, restructuring costs maximum									500,000
Minimum debt service coverage ratio				1.20		1.20
Amended And Restated Credit Agreement | Debt Instrument, Period One
Debt Instrument [Line Items]
Debt instrument, covenant, purchase and enterprise resource planning costs maximum									200,000
Amended And Restated Credit Agreement | Debt Instrument, Period Two
Debt Instrument [Line Items]
Debt instrument, covenant, purchase and enterprise resource planning costs maximum									$ 100,000
Amended And Restated Credit Agreement | Fiscal Quarter Ending September 30, 2020
Debt Instrument [Line Items]
Debt instrument, total covenant, leverage ratio				3.75		3.75
Debt instrument, covenant, multiplier						400.00%
Amended And Restated Credit Agreement | Fiscal Quarter Ending December 31, 2020
Debt Instrument [Line Items]
Debt instrument, total covenant, leverage ratio				3.50		3.50
Debt instrument, covenant, multiplier						200.00%
Amended And Restated Credit Agreement | Fiscal Quarter Ending March 31, 2021
Debt Instrument [Line Items]
Debt instrument, total covenant, leverage ratio				3.25		3.25
Debt instrument, covenant, multiplier						133.30%
Amended And Restated Credit Agreement | Fiscal Quarter Ending June 30, 2021
Debt Instrument [Line Items]
Debt instrument, total covenant, leverage ratio				3.25		3.25
Amended And Restated Credit Agreement | Fiscal Quarter Thereafter
Debt Instrument [Line Items]
Debt instrument, total covenant, leverage ratio				3		3
Amended And Restated Credit Agreement | PPP under CARES Act
Debt Instrument [Line Items]
Debt instrument, covenant, debt amount, maximum		$ 6,000,000
Amended And Restated Credit Agreement | Line of credit | Secured debt
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 73,000,000
Amended And Restated Credit Agreement | Line of credit | Secured debt | Base Rate | Minimum | PPP under CARES Act
Debt Instrument [Line Items]
Basis spread on variable rate		2.00%
Amended And Restated Credit Agreement | Line of credit | Secured debt | LIBOR | Minimum | PPP under CARES Act
Debt Instrument [Line Items]
Basis spread on variable rate		1.00%
New US Term Loan | Line of credit | Secured debt
Debt Instrument [Line Items]
Outstanding principal amount				$ 21,665,000		$ 21,665,000		22,768,000
Effective interest rate				5.50%		5.50%
Unamortized discount				$ 200,000		$ 200,000
Capital expenditure line | Line of credit
Debt Instrument [Line Items]
Outstanding principal amount				$ 1,134,000		$ 1,134,000		$ 1,220,000
Effective interest rate				5.50%		5.50%
Forbearance Agreement | Line of credit | Secured debt
Debt Instrument [Line Items]
Paid-in-kind percentage				0.50%		0.50%
First Amendment To Forbearance Agreement | Line of credit | Secured debt | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate	4.50%		4.25%
US Borrower And CA Borrower | US Term loan | Line of credit | Secured debt
Debt Instrument [Line Items]
Maximum increase to principal amount			$ 26,000,000
US Borrower And CA Borrower | CA term loan | Line of credit | Secured debt
Debt Instrument [Line Items]
Outstanding principal amount			$ 12,000,000
US Borrower And CA Borrower | Amended And Restated Credit Agreement | Line of credit
Debt Instrument [Line Items]
Debt instrument, term			5 years
Debt instrument, term to fund capital expenditures			2 years
US Borrower And CA Borrower | Amended And Restated Credit Agreement | Line of credit | Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 30,000,000
November 8, 2018 Through November 8, 2019 | US Borrower And CA Borrower | Amended And Restated Credit Agreement | Capital expenditure line
Debt Instrument [Line Items]
Maximum borrowing capacity			2,500,000
November 9, 2019 Through November 8, 2020 | US Borrower And CA Borrower | Amended And Restated Credit Agreement | Capital expenditure line
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 5,000,000
December 31, 2018 Through September 30, 2020 | New US Term Loan | Line of credit | Secured debt
Debt Instrument [Line Items]
Principal payment						$ 337,500
October 1, 2020 Through September 30, 2021 | New US Term Loan | Line of credit | Secured debt
Debt Instrument [Line Items]
Principal payment						$ 575,000
October 1, 2020 Through September 30, 2021 | Capital expenditure line | Line of credit
Debt Instrument [Line Items]
Percent of principal payment						10.00%
October 1, 2021 Through November 7, 2023 | CA term loan | Line of credit | Secured debt
Debt Instrument [Line Items]
Principal payment						$ 400,000
October 1, 2021 Through November 7, 2023 | New US Term Loan | Line of credit | Secured debt
Debt Instrument [Line Items]
Principal payment						$ 812,500
October 1, 2021 Through November 7, 2023 | Capital expenditure line | Line of credit
Debt Instrument [Line Items]
Percent of principal payment						12.50%
December 31, 2018 Through November 7, 2023 | CA term loan | Line of credit | Secured debt
Debt Instrument [Line Items]
Principal payment						$ 375,000
December 31, 2019 Through September 30, 2020 | Capital expenditure line | Line of credit
Debt Instrument [Line Items]
Percent of principal payment						7.50%
December 31, 2020 Through September 30, 2021 | Capital expenditure line | Line of credit
Debt Instrument [Line Items]
Percent of principal payment						10.00%
December 31, 2021 Through November 7, 2023 | Capital expenditure line | Line of credit
Debt Instrument [Line Items]
Percent of principal payment						12.50%

Long-term Debt - Schedule of Mi

Long-term Debt - Schedule of Minimum Borrowers Liquidity (Details) - Forbearance Agreement - Line of credit - Secured debt	Jun. 30, 2021USD ($)
Date of Determination July 31, 2021
Debt Instrument [Line Items]
Minimum Liquidity	$ 250,000
Date of Determination August 31, 2021
Debt Instrument [Line Items]
Minimum Liquidity	250,000
Date of Determination September 30, 2021
Debt Instrument [Line Items]
Minimum Liquidity	500,000
Date of Determination October 31, 2021
Debt Instrument [Line Items]
Minimum Liquidity	1,000,000
Date of Determination November 30, 2021
Debt Instrument [Line Items]
Minimum Liquidity	1,600,000
Date of Determination December 31, 2021
Debt Instrument [Line Items]
Minimum Liquidity	1,600,000
Date of Determination January 31, 2022
Debt Instrument [Line Items]
Minimum Liquidity	2,800,000
Date of Determination February 28, 2022
Debt Instrument [Line Items]
Minimum Liquidity	$ 3,200,000

Long-term Debt - Minimum Consol

Long-term Debt - Minimum Consolidated EBITDA (Details) - Forbearance Agreement	Jun. 30, 2021USD ($)
Trailing 4 months
Debt Instrument [Line Items]
Minimum Consolidated EBITDA	$ 300,000
Trailing 5 months
Debt Instrument [Line Items]
Minimum Consolidated EBITDA	1,300,000
Trailing 6 months
Debt Instrument [Line Items]
Minimum Consolidated EBITDA	2,450,000
Trailing 7 months
Debt Instrument [Line Items]
Minimum Consolidated EBITDA	3,400,000
Trailing 8 months
Debt Instrument [Line Items]
Minimum Consolidated EBITDA	4,200,000
Trailing 9 months
Debt Instrument [Line Items]
Minimum Consolidated EBITDA	5,025,000
Trailing 10 months
Debt Instrument [Line Items]
Minimum Consolidated EBITDA	5,925,000
Trailing 11 months
Debt Instrument [Line Items]
Minimum Consolidated EBITDA	$ 6,900,000

Long-term Debt - Schedule of Re

Long-term Debt - Schedule of Repayment of Maturities (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
2021	$ 5,393
2022	49,634
2023	0
Total	55,027
Discounts	(235)	$ (300)
Debt issuance costs	(312)
Total debt, net	$ 54,480

Derivative Financial Instrume_2

Derivative Financial Instruments (Details) - Interest rate swap - Not designated as hedging instrument - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Nov. 30, 2018
Derivatives, Fair Value [Line Items]
Fixed interest rate					3.075%
Notional amount					$ 5
Derivative fair value assets (liabilities)	$ (0.9)	$ (1.5)	$ (0.9)	$ (1.5)
Interest expense
Derivatives, Fair Value [Line Items]
Monthly settlement payments (receipts)	$ 0.1	$ 0.2	$ 0.3	$ 1
Derivative Instrument, Periodic Payment, Installment Periods Through June Twenty Eight Two Thousand Nineteen
Derivatives, Fair Value [Line Items]
Notional amount					17.5
Quarterly increase in notional amount					0.4
Derivative Instrument, Periodic Payment, Installment Periods Until September Thirty Two Thousand Twenty
Derivatives, Fair Value [Line Items]
Notional amount					17.5
Quarterly decrease in notional amount					0.2
Derivative Instrument, Periodic Payment, Installment Periods Until December Thirty First Twenty Twenty One
Derivatives, Fair Value [Line Items]
Quarterly decrease in notional amount					0.4
Derivative Instrument, Periodic Payment, Installment Periods Until November Eighth Twenty Twenty Three
Derivatives, Fair Value [Line Items]
Quarterly decrease in notional amount					$ 0.6

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) $ in Millions	Nov. 07, 2019employee	Jul. 16, 2019employee	Jun. 30, 2021USD ($)	Dec. 31, 2020USD ($)
Bryan Restructuring
Restructuring Cost and Reserve [Line Items]
Number of position eliminations	43
Evansville Restructuring
Restructuring Cost and Reserve [Line Items]
Number of position eliminations		47
Remaining lease payments | $			$ 0.5	$ 0.7
Sublease of facility, percentage			11.00%

Restructuring - Schedule of Res

Restructuring - Schedule of Restructuring Liability (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Restructuring Reserve [Roll Forward]
Beginning accrual balance				$ 554
Provision for estimated expenses to be incurred	$ 0	$ 273	$ 0	1,193
Payments made during the year and asset write offs				1,238
Ending accrual balance		508		508
Employee Termination Benefits Liability
Restructuring Reserve [Roll Forward]
Beginning accrual balance				438
Provision for estimated expenses to be incurred				0
Payments made during the year and asset write offs				400
Ending accrual balance		38		38
Other Exit Costs Liability
Restructuring Reserve [Roll Forward]
Beginning accrual balance				116
Provision for estimated expenses to be incurred				1,193
Payments made during the year and asset write offs				838
Ending accrual balance		$ 470		$ 470

Stock Incentive Plans - Additio

Stock Incentive Plans - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands

May 04, 2025

May 04, 2024

May 04, 2023

May 04, 2022

Jun. 11, 2021

May 04, 2021

Jun. 30, 2021

Jun. 30, 2020

Jun. 30, 2021

Jun. 30, 2020

Dec. 29, 2013

Jul. 31, 2020

Jun. 30, 2016

Jan. 04, 2015

Employee Stock Option

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]

Unrecognized compensation cost

$ 689

$ 689

Compensation cost, weighted average period

4 years 1 month 6 days

Selling, General and Administrative Expenses

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]

Allocated share-based compensation expense

$ 256

$ 32

$ 283

$ 55

The 2013 Stock Incentive Plan

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]

Number of shares reserved for future issuance (in shares)

495,000

Exercise price (in dollars per share)

$ 3.31

Vested, weighted average grant date fair value (in dollars per share)

$ 1.64

The 2013 Stock Incentive Plan | Employee Stock Option

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]

Number of shares available for grant (in shares)

495,000

Expiration period

10 years

Number of shares authorized (in shares)

38,943

2014 Omnibus Performance Award Plan

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]

Number of shares authorized (in shares)

700,000

450,000

250,000

Exercise price (in dollars per share)

$ 4.51

Vested and nonvested, weighted average grant date fair value (in dollars per share)

$ 2.28

2014 Omnibus Performance Award Plan | Employee Stock Option

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]

Number of shares authorized (in shares)

59,254

139,278

Exercise price (in dollars per share)

$ 3.31

Vested, weighted average grant date fair value (in dollars per share)

$ 1.64

2014 Omnibus Performance Award Plan | Employee Stock Option | Award vesting, period one

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]

Award vesting rights, percentage

20.00%

2014 Omnibus Performance Award Plan | Employee Stock Option | Forecast | Award vesting, period two

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]

Award vesting rights, percentage

20.00%

2014 Omnibus Performance Award Plan | Employee Stock Option | Forecast | Award vesting, period three

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]

Award vesting rights, percentage

20.00%

2014 Omnibus Performance Award Plan | Employee Stock Option | Forecast | Award vesting, period four

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]

Award vesting rights, percentage

20.00%

2014 Omnibus Performance Award Plan | Employee Stock Option | Forecast | Award vesting period, five

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]

Award vesting rights, percentage

20.00%

Stock Incentive Plans - Schedul

Stock Incentive Plans - Schedule of Stock Options and Stock Awards (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Number of Shares
Outstanding at end of period (in shares)	948,975
Aggregate Intrinsic Value
Share price (in dollars per share)	$ 3.70	$ 5.50
The Plan and the 2014 Plan
Number of Shares
Outstanding at beginning of period (in shares)	726,500
Granted (in shares)	237,475
Exercised (in shares)	0
Forfeited or expired (in shares)	15,000
Outstanding at end of period (in shares)	948,975	726,500
Vested and exercisable (in shares)	454,553
Weighted Average Exercise Price
Outstanding at beginning of period (in dollars per share)	$ 4.53
Granted (in dollars per share)	4.01
Exercised (in dollars per share)	0
Forfeited (in dollars per share)	12.50
Outstanding at end of period (in dollars per share)	4.27	$ 4.53
Vested and exercisable (in dollars per share)	$ 5.25
Weighted Average Remaining Contractual Term (in years)
Outstanding weighted average remaining contractual term	7 years 7 months 6 days	7 years 2 months 12 days
Granted	4 years 3 months 18 days
Exercised	0 years
Forfeited or expired	0 years
Vested and exercisable	6 years 1 month 6 days
Aggregate Intrinsic Value
Outstanding, beginning of period (in shares)		1,484,000
Forfeited or expired (in shares)	0
Outstanding, end of period (in shares)	$ 444
Vested and exercisable at end of period (in shares)	$ 169

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ 296	$ (1,058)	$ 738	$ (1,659)
Actual effective rate	(13.00%)		(26.00%)
Statutory rate	21.00%		21.00%

Leases - Additional Information

Leases - Additional Information (Details)	Jun. 30, 2021
Minimum
Lessee, Lease, Description [Line Items]
Renewal term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Renewal term	5 years

Leases - Balance Sheet Informat

Leases - Balance Sheet Information (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Right-of-Use-Assets
Operating	$ 9,274	$ 10,415
Liabilities
Operating lease, liability, current	$ 1,964
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other accrued liabilities
Operating lease, liability, non-current	$ 8,168
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other liabilities
Total lease liabilities	$ 10,132

Leases - Lease Cost (Details)

Leases - Lease Cost (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)
Leases [Abstract]
Cost of sales, selling expenses and general and administrative expense	$ 1,307

Leases - Schedule of Lease Liab

Leases - Schedule of Lease Liabilities Maturity (Details) $ in Thousands	Jun. 30, 2021USD ($)
Leases [Abstract]
2021 (remainder)	$ 1,446
2022	2,058
2023	1,381
2024	1,296
2025	1,288
Thereafter	5,413
Total lease payments	12,882
Less: interest	2,751
Present value of lease payments	$ 10,132

Leases - Weighted-Average Lease

Leases - Weighted-Average Lease Information (Details)	Jun. 30, 2021
Leases [Abstract]
Weighted average remaining lease term (years)	7 years
Weighted average discount rate	6.50%

Leases - Cash Outflow Informati

Leases - Cash Outflow Information (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)
Leases [Abstract]
Operating cash outflows from operating leases	$ 1,531

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Defined Benefit Plan Disclosure [Line Items]
Employer contribution amount	$ 0.1	$ 0.1	$ 0.2	$ 0.2
Defined contribution plan, initial contribution
Defined Benefit Plan Disclosure [Line Items]
Employer matching contribution, percent			100.00%
Employer matching contribution, percent of employees gross pay			3.00%
Defined contribution plan, additional contribution
Defined Benefit Plan Disclosure [Line Items]
Employer matching contribution, percent			50.00%
Employer matching contribution, percent of employees gross pay			2.00%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	Mar. 18, 2013	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Jun. 30, 2020
Affiliated Entity | Management Agreement
Related Party Transaction [Line Items]
Annual management fees	$ 300
Expenses from agreement			$ 56	$ 56	$ 110
Management agreement, term	5 years
Additional renewal period term	1 year
Equity ownership needed to terminate agreement	50.00%
Engauge Workforce Solutions LLC ("Engauge")
Related Party Transaction [Line Items]
Expenses from agreement		$ 228
Agreement term			12 months
Written notice term			60 days

Earnings Per Share - Numerator

Earnings Per Share - Numerator and Denominator of Basic and Diluted Loss per Share Reconciliation (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020
Numerator:
Net income (loss)	$ (2,509)	$ (1,069)	$ (4,322)	$ (2,302)	$ (3,578)	$ (6,624)
Denominator:
Weighted average shares outstanding, basic (in shares)	9,779,147		9,779,147		9,779,147	9,779,147
Dilutive effect of stock-based awards (in shares)	0		0		0	0
Weighted average shares outstanding, diluted (in shares)	9,779,147		9,779,147		9,779,147	9,779,147
Earnings Per Share, Basic and Diluted [Abstract]
Basic loss per share (in dollars per share)	$ (0.26)		$ (0.44)		$ (0.37)	$ (0.68)
Diluted loss per share (in dollars per share)	$ (0.26)		$ (0.44)		$ (0.37)	$ (0.68)

Earnings Per Share - Anti-Dilut

Earnings Per Share - Anti-Dilutive Common Stock Equivalents Summary (Details) - $ / shares	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of options (in shares)	948,975	611,480
Exercise price of options lower limit (in dollars per share)	$ 2.36	$ 2.36
Exercise price of options upper limit (in dollars per share)	$ 12.58	$ 12.58
Warrants (in shares)		142,185
Exercise price of warrants lower limit (in dollars per share)		$ 11.88
Minimum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Exercise price of warrants lower limit (in dollars per share)		3.33
Maximum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Exercise price of warrants lower limit (in dollars per share)		$ 11.88
Warrants for Underwriters
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of EPS (in shares)		141,000